Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective-Reference-Cited by-同舟云学术

Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective

Published:2020-06-15 Issue:18 Volume:63 Page:10109-10134
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kadayat Tara Man¹,Shrestha Aarajana¹²,Jeon Yong Hyun³⁴^ORCID,An Hongchan¹^ORCID,Kim Jina¹,Cho Sung Jin¹⁴^ORCID,Chin Jungwook¹^ORCID

Affiliation:

1. New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea

2. College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea

3. Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea

4. Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu 41404, Republic of Korea

Funder

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01882

Reference191 articles.

1. The Mechanisms of Action of PPARs

2. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes

3. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders

4. PPARβ/δ in human cancer

5. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the therapeutic potential of PPARδ agonist bearing 1,3,4- thiadiazole in inflammatory disorders;European Journal of Medicinal Chemistry;2024-12

2. Development of a Robust Read-Across Model for the Prediction of Biological Potency of Novel Peroxisome Proliferator-Activated Receptor Delta Agonists;International Journal of Molecular Sciences;2024-05-10

3. Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator;Future Pharmacology;2023-12-15

4. Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review;Biomedicines;2023-06-04

5. Peroxisome proliferator-activated receptors regulate the progression and treatment of gastrointestinal cancers;Frontiers in Pharmacology;2023-03-21